StockGuru Morning Alerts for Thursday, November 2, 2006 Featuring The Immune Response Corporation, EnXnet, Rotoblock, Northamerican Energy, ALR Technologies, and GeneThera
The Immune Response Corporation (OTCBB: IMNR) The Immune Response Corporation (OTCBB: IMNR) - Wednesday’s shares closed down 4.02% to $0.0191. 1,819,291 shares were traded. The Immune Response Corporation announced on October 30th that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New York City. The Company’s presentation to the investment community will take place on Tuesday, November 7, 2006, at 3:55 p.m. (EST). Dr. O’Neill will discuss a key strategic agreement, signed October 10, 2006, with Accelsiors…